Free Trial

Perspective Therapeutics (CATX) SEC Filings & 10K Form

Perspective Therapeutics logo
$3.68 +0.05 (+1.38%)
Closing price 04:00 PM Eastern
Extended Trading
$3.66 -0.03 (-0.68%)
As of 07:43 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Perspective Therapeutics SEC Filings

DateFilerForm TypeView
07/03/2025
7:02 AM
Perspective Therapeutics, Inc. (Filer)
Perspective Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/23/2025
5:32 AM
Perspective Therapeutics, Inc. (Filer)
Perspective Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/03/2025
7:05 AM
Perspective Therapeutics, Inc. (Filer)
Perspective Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/30/2025
4:23 PM
Perspective Therapeutics, Inc. (Filer)
Perspective Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/28/2025
4:23 PM
Perspective Therapeutics, Inc. (Filer)
Perspective Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/12/2025
3:30 PM
Perspective Therapeutics, Inc. (Filer)
Perspective Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/01/2025
4:05 PM
Perspective Therapeutics, Inc. (Filer)
Perspective Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2025
6:10 AM
Perspective Therapeutics, Inc. (Filer)
Perspective Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/16/2025
3:30 PM
Perspective Therapeutics, Inc. (Filer)
Perspective Therapeutics (Filer)
Form DEF 14A
04/16/2025
3:31 PM
Perspective Therapeutics, Inc. (Filer)
Perspective Therapeutics (Filer)
Form DEFA14A
04/11/2025
6:08 AM
Perspective Therapeutics, Inc. (Filer)
Perspective Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/08/2025
11:15 PM
Perspective Therapeutics, Inc. (Filer)
Perspective Therapeutics (Filer)
Form EFFECT
04/04/2025
4:15 PM
Perspective Therapeutics, Inc. (Filer)
Perspective Therapeutics (Filer)
Form POS AM
04/01/2025
5:44 PM
Perspective Therapeutics, Inc. (Issuer)
Perspective Therapeutics (Issuer)
Spoor Johan M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2025
4:03 PM
Perspective Therapeutics, Inc. (Issuer)
Perspective Therapeutics (Issuer)
Woods Lori A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2025
4:03 PM
Graham Juan (Reporting)
Perspective Therapeutics, Inc. (Issuer)
Perspective Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2025
4:04 PM
Perspective Therapeutics, Inc. (Issuer)
Perspective Therapeutics (Issuer)
Williamson Robert F III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2025
10:39 AM
Perspective Therapeutics, Inc. (Filer)
Perspective Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/26/2025
4:07 PM
Perspective Therapeutics, Inc. (Filer)
Perspective Therapeutics (Filer)
Form POS AM
03/17/2025
6:05 AM
Perspective Therapeutics, Inc. (Filer)
Perspective Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/05/2025
3:29 PM
Perspective Therapeutics, Inc. (Issuer)
Perspective Therapeutics (Issuer)
Puhlmann Markus (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
7:00 AM
Perspective Therapeutics, Inc. (Filer)
Perspective Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2025
10:37 AM
JANUS HENDERSON GROUP PLC (Filed by)
Perspective Therapeutics, Inc. (Subject)
Perspective Therapeutics (Subject)
Form SCHEDULE 13G/A
02/14/2025
9:26 AM
Avidity Partners Management LP (Filed by)
Perspective Therapeutics, Inc. (Subject)
Perspective Therapeutics (Subject)
Form SCHEDULE 13G/A
02/03/2025
3:09 PM
Perspective Therapeutics, Inc. (Filer)
Perspective Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/24/2025
6:26 AM
Perspective Therapeutics, Inc. (Filer)
Perspective Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/13/2025
7:36 AM
Perspective Therapeutics, Inc. (Filer)
Perspective Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/07/2025
3:50 PM
Graham Juan (Reporting)
Perspective Therapeutics, Inc. (Issuer)
Perspective Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
7:05 AM
Perspective Therapeutics, Inc. (Filer)
Perspective Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/03/2024
8:31 PM
Perspective Therapeutics, Inc. (Filer)
Perspective Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/27/2024
6:00 AM
Hunt Jonathan Robert (Reporting)
Perspective Therapeutics, Inc. (Issuer)
Perspective Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2024
6:05 AM
Perspective Therapeutics, Inc. (Issuer)
Perspective Therapeutics (Issuer)
Williamson Robert F III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/26/2024
6:00 AM
Perspective Therapeutics, Inc. (Issuer)
Perspective Therapeutics (Issuer)
Spoor Johan M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2024
6:30 AM
Perspective Therapeutics, Inc. (Filer)
Perspective Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/15/2024
6:30 AM
Perspective Therapeutics, Inc. (Filer)
Perspective Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
5:14 PM
Avidity Partners Management LP (Filed by)
Perspective Therapeutics, Inc. (Subject)
Perspective Therapeutics (Subject)
Form SC 13G
11/14/2024
9:24 AM
JANUS HENDERSON GROUP PLC (Filed by)
Perspective Therapeutics, Inc. (Subject)
Perspective Therapeutics (Subject)
Form SC 13G
11/07/2024
8:24 AM
FMR LLC (Filed by)
Perspective Therapeutics, Inc. (Subject)
Perspective Therapeutics (Subject)
Form SC 13G/A
11/07/2024
8:12 AM
FMR LLC (Filed by)
Perspective Therapeutics, Inc. (Subject)
Perspective Therapeutics (Subject)
Form SC 13G
10/11/2024
7:31 AM
Perspective Therapeutics, Inc. (Filer)
Perspective Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/12/2024
1:44 PM
Austin Mark John (Reporting)
Perspective Therapeutics, Inc. (Subject)
Perspective Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
He Called Nvidia at $1.10. Now, He Says THIS Stock Will… (Ad)

The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvidia at $1.10 reveals AI’s Next Magnificent Seven… including one stock he says could become America’s next trillion-dollar giant.

See his full breakdown of the seven stocks to own now
09/05/2024
6:05 AM
Perspective Therapeutics, Inc. (Filer)
Perspective Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/30/2024
3:10 PM
Perspective Therapeutics, Inc. (Filer)
Perspective Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/19/2024
4:20 PM
Perspective Therapeutics, Inc. (Filer)
Perspective Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2024
4:11 PM
Perspective Therapeutics, Inc. (Filer)
Perspective Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2024
3:32 PM
Perspective Therapeutics, Inc. (Filer)
Perspective Therapeutics (Filer)
Form 424B5
08/12/2024
8:41 PM
Perspective Therapeutics, Inc. (Filer)
Perspective Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2024
4:22 PM
Perspective Therapeutics, Inc. (Filer)
Perspective Therapeutics (Filer)
Form 8-K/A
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NYSE:CATX) was last updated on 8/8/2025 by MarketBeat.com Staff
From Our Partners